Global poultry vaccines market is likely to exhibit a promising growth curve as far as the short-term outlook is considered. The report will uncover the insights into how the market growth will unfold in the next few years.
Poultry Vaccines Market Proliferates in Line with Soaring R&D Investments, and Growing Emphasis on Food Security
Some of the major factors driving the growth of poultry vaccines market include increasing product R&D, rising poultry disease incidence, desire for secure food sources, awareness of and measures to combat antimicrobial resistance, and rising antimicrobial resistance. With the release of EVANT, an attenuated broil vaccine, in 2019, HIPRA expanded its coccidiosis vaccines. The growing demand for meat internationally, government efforts, rising interest in foods connected to poultry, most recent vaccine breakthroughs, and a rise in poultry health care consumption are other factors propelling the expansion of the global poultry vaccines market. Demand for poultry vaccinations is anticipated to increase due to the growing chicken population and avian disease prevalence. Consuming contaminated meat puts human health in danger. Thus the birds must receive vaccinations before being used. The rapid spread of diseases, and the shortage of effective treatments are the main challenges encountered by poultry farms. It becomes necessary to be vaccinated to avoid such occurrences.
Brazil had 14.6 million chicken livestock units in 2019 compared to 19.72 million in the United States. The enormous flock size suggests that many birds are vulnerable to avian diseases, which can be avoided with timely immunizations. Research suggests that there were 22 new avian outbreaks worldwide. In 2020, there were an anticipated 836 new outbreaks, totaling 2.79 million cases. A major factor influencing the poultry vaccines market is thus the rise in the frequency of disease outbreaks in the avian population. Low pathogenic avian influenza found in poultry in Italy and highly pathogenic avian influenza discovered in Russia in October 2021 are two of the most recent disease announcements. A major market player has introduced new products with enhanced capabilities. They have made essential actions to increase the devices' accuracy and general performance.
Poultry Vaccines Market: COVID-19 Impact
The COVID-19 pandemic hurt the poultry industry by reducing demand, which led to reduced sales, unsold supplies, and lower prices for chicken meat and eggs. The effect is more noticeable in nations like India, where there are large chickens. Although the production of eggs, milk, and the meat was among the critical services, the supply chain was hampered by the lockdown and mobility restrictions. The pandemic's negative effects were worsened by these obstacles, and the appearance and widespread concern of other avian diseases, like bird flu in India. However, the COVID-19 pandemic has allowed vaccine producers to use it to increase their market share. This is due to the growing awareness of animal illnesses, the need for safe food and products, and the concern over zoonoses.
Increase in Disease Prevalence in Poultry to Propel Growth of Poultry Vaccines Market
By hastening the production of antibodies by the bird's immune system to fight against invaders, poultry vaccines help prevent a particular disease. The control of poultry diseases and the prevention of viral diseases depend heavily on poultry vaccinations. The negative consequences of particular conditions that can cause issues, such as infections in a flock of poultry, are prevented or lessened via vaccination. To prevent infectious poultry diseases and reduce the emergence of clinical diseases at the farm level, which will increase productivity, poultry vaccinations are frequently used. The main diseases that affect poultry are zoonotic illnesses, avian influenza viruses, and bird flu. For instance, 1,672 cases of the highly pathogenic avian influenza (HPAI) virus were discovered in 580 cases in poultry, 1,051 cases in wild, and 41 in captive birds between February and May 2021 in 24 EU/EEA nations and the UK. As a result, the demand for chicken vaccinations is increasing along with the prevalence of numerous poultry diseases, fueling the expansion of the poultry vaccines market.
Rising Demand for Advanced and Effective Immunization Products to Drive Poultry Vaccines Market Growth
The later introduction of poultry care products, and technology improvements are further important driving forces for poultry vaccines market. Since they were originally made accessible to the general public, important R&D advancements have been produced in poultry vaccination. Animal and human health protection has greatly benefited from poultry immunization using conventionally attenuated and inactivated pathogens. However, the inactivated vaccines frequently only partially replicate the limitations of the classic or conventional animal vaccination, such as the complex immunogenicity of several bacterial infections. Recombinant vaccines were created due to these circumstances, and they have several benefits, including not exposing those receiving the vaccine to the pathogen.
Inadequate Adoption of Vaccination Among Smallholder Farmers Limits Poultry Vaccines Market Growth
Between 600 and 900 million smallholder farmers are in charge of raising livestock in the emerging nations of Asia, Africa, and Latin America. The adoption of poultry immunization among these smallholder farmers is constrained by several problems, including a lack of knowledge about their advantages, an inability to access them because the cost of the immunization products is too high, and a lack of availability because of the supply chain's fragility. With a significant percentage of their livestock animals passing away from various diseases, smallholder farmers experience additional financial strain. Governments and organizations are using a variety of tactics to increase accessibility, availability, and affordability to increase the uptake of animal immunization among smallholder farmers.
Attenuated Live Vaccines Remain Dominant in Poultry Vaccines Market on the Back of Longer Shelf-life
In the forecast period, the sector with the highest revenue share was attenuated live vaccines. Compared to other immunizations, these vaccines can cause the immune system to manufacture more antibodies. Additionally, immunization has a longer shelf-life and offers defense against avian illnesses such as bronchitis, bursitis, and Newcastle disease. The market is developing due to expanding R&D efforts, particularly in the vaccination area, to stop various disease outbreaks. The poultry vaccines market is growing due to numerous government entities launching measures to emphasize immunization. Additionally, a rise in demand for programs meant to stop the spread of the disease and lessen suffering will accelerate the expansion of poultry vaccines market during the study period.
Avian Influenza to Dominate Poultry Vaccines Market with its Increased Human Transmission
Avian influenza is a viral illness affecting birds and is present in all nations. The condition can range in severity from minor to severe. Humans can contract avian influenza through close contact. Disease epidemics have been documented in nations including the United States, Asia, and Europe. They are licensed only if the vaccines meet the requirements outlined by the World Organization for Animal Health. The avian influenza vaccine is administered to immunize recipients against the hemagglutinin (HA) protein. According to the CDC, this condition has a death rate of between 90-100%. This demonstrates that there is a high chance of the disease. As a result, regulatory agencies are increasingly quickening the licensing procedure for certain vaccines connected to veterinary health.
Consistently Rising Poultry Product Consumption Continues to Seal Top Position for North America in Poultry Vaccines Market
A major portion of the global market for poultry vaccines is expected to be dominated by North America for the duration of the forecasted period due to rising consumption of products derived from poultry, growing consumer concern over food safety, and rising prevalence of zoonotic diseases linked to poultry. In 2021, Americans consumed 96.5 pounds of broiler meat per person and by 2022, that number is expected to rise slightly to 96.9 pounds. The region's production of eggs and hens has increased. In the United States, approximately 110.7 billion eggs were produced in 2021. In North America, live vector vaccines, non-replicating recombinant antigen vaccines, nucleic acid-mediated vaccinations, and vaccines with living genes removed have all been developed. This will probably support the growth of poultry vaccines market expansion over the foreseeable future.
Over the projection period, Asia Pacific is anticipated to grow at a rapid rate. This is due to increased vaccination awareness campaigns and a growing public understanding of poultry vaccinations. Rising government initiatives and quick advancements in animal husbandry techniques are further causes. Owners of companion and livestock animals in India, China, Japan, and the rest of Asia Pacific are interested in administering vaccinations on a regular and timely basis. This would fuel the expansion of poultry vaccines market throughout the area. High R&D spending by numerous key players and increased attempts to commercialize poultry vaccines and inoculations at tolerably low prices drive the industry.
Global Poultry Vaccines Market: Competitive Landscape
In May 2022, Boehringer Ingelheim, a global pioneer in animal health, introduced TwistPak®, a unique mixing platform. It enables pig farmers to mix two vaccines, Ingelvac CircoFLEX® and Ingelvac MycoFLEX®, in a practical, quick, and flexible manner. TwistPak® will be available globally in all certified presentation sizes beginning in May this year. In November 2020, HIPRA Indonesia announced the virtual launch of GUMBOHATCH's new generation Infectious Bursal Disease immune complex immunization solution for broiler chickens. A new generation of immune-complex vaccines has been created as a result of all these developments, ensuring vaccination potency and uniformity in the field while removing the possibility of immunosuppression.
A few of the players in the poultry vaccines market include Boehringer Ingelheim International GmbH, Ceva, Zoetis, Elanco, Intervet Inc., a Subsidiary of Merck & Co., Inc., Hester Biosciences Limited, Vaxxinova International BV, Venkys India, Calier, KM Biologics, and Phibro Animal Health Corporation.
Regional Classification of Global Poultry Vaccines Market is Listed Below:
Middle East and Africa
*Regions and countries are subject to change based on data availability.
Key Elements Included In The Study: Global Poultry Vaccines Market
Post Sale Support, Research Updates & Offerings
We value the trust shown by our customers in Fairfield Market Research. We support our clients through our post sale support, research updates and offerings.
Considering the volatility of business today, traditional approaches to strategizing a game plan can be unfruitful if not detrimental. True ambiguity is no way to determine a forecast. A myriad of predetermined factors must be accounted for such as the degree of risk involved, the magnitude of circumstances, as well as conditions or consequences that are not known or unpredictable. To circumvent binary views that cast uncertainty, the application of market research intelligence to strategically posture, move, and enable actionable outcomes is necessary.View Methodology